Our data showed for the first time that TLR1-N248S was associated with the clinical outcome of patients with locally advanced stage III COAD, suggesting that this genetic defect might be associated with the risk of lymph node metastasis and poor DMFS. The gene discussed is TLR1; the disease is metastatic malignant neoplasm in the lymph nodes.